מכאן שהרפואה המשולבת, זו המנסה לעשות שימוש בשני העולמות, הקונבנציונלי והאלטרנטיבי, מתמקדת באדם לא פחות מאשר במחלה. ...
מתוך הערך: המדריך לטיפול בסוכרת

המלצות כוח המשימה הישראלי בנושא קידום בריאות ורפואה מונעת/תוספת ביבליוגרפיה למהדורת 2008

מתוך ויקירפואה

המלצות כוח המשימה הישראלי בנושא
קידום בריאות ורפואה מונעת
Ambox warning blue.png
ערך זה הוא הנחיה קלינית סגורה לעריכה
המלצות כוח המשימה.png
שם הפרק תוספת ביבליוגרפיה למהדורת 2008
עורך מדעי פרופ' חוה טבנקין, ד"ר אמנון להד - איגוד רופאי המשפחה
מוציא לאור ההסתדרות הרפואית בישראל, האגף למדיניות רפואית, איגוד רופאי המשפחה בישראל
מועד הוצאה מהדורת 2013
מספר עמודים 249
Logo small.gif


בריאות האישה: אוסטיאופורוזיס

  • 429    Sornay-Rendu E et al. Identification of osteopenic women at high risk of fractures: the OFELY study. J Bone Miner Res. 2005: 20 (10): 1813-9.
  • 430.   Siris ES, Chen YT, Abbott TA et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 2004; 164: 1108-12.
  • 431.   Van der Klift M et al. The incidence of vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res 2002; 17:1051-6.
  • 432.   Khosla S, Melton LJ 3rd. Clinical practice. Osteopenia. N Eng J Med 2007; 356 (22): 2293-2300.
  • 433.   Martyn-St James M, Carroll S. High-intensity resistance training and postmenopausal bone loss: a meta-analysis. Osteoporos Int 2006; 17: 1225-1240.
  • 434.   Palombaro KM. Effects of walking-only interventions on bone mineral density at various skeletal sites: a meta-analysis. J Geriatr Phys Ther 2005; 28: 102-7.
  • 435.   Kanis JA, Johnell 0, Black DM et al. Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial. Bone 2003; 33: 293-300.
  • 436.   Martino S, Cauley JA, Barrett-Connor E et al; CORE Investigators. Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst 2004; 96: 1751-61.
  • 437.   Bone HG, Hosking D, Devogelaer JP, Tucci JR et al; Alendronate Phase III Osteoporosis Treatment Study Group. Ten years' experience with Alendronate for osteoporosis in postmenopausal women. N Engl J Med 2004; 350: 1189-99.
  • 438.   Harrington JT et al. Risedronate rapidly reduces the risk for nonvertebral fractures in women with post menopausal osteoporosis. Calcif Tissue Int. 2004 74: 129-135.
  • 439.   Rosen CJ, Hochberg MC, Bonnick SL et al ; Fosamax Actonel Comparison Trial Investigators. Treatment with once-weekly Alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study. J Bone Miner Res 2005; 20: 141-51.
  • 440.   Silverman SL, Watts NB, Delmas PD et al. Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and Alendronate (REAL) cohort study. Osteoporos Int. 2007; 18: 25-34.
  • 441.   Black DM, Delmas PD, et al ; HORIZON Pivotal Fracture Trial. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Eng J Med 2007; 356 (18): 1809¬1822.
  • 442.   Reid IR, Brown JP, Burckhardt P, Horowitz Z et al. Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med 2002; 346: 653-61.

גיל המעבר וטיפול הורמונלי

  • 443.   Graham L. NAMS Releases Updated Position Statement on the Use of Estrogen and Progestogen in Perimenopausal and Postmenopausal Women. Am Fam Physician 2007; 76 (2): 295-298.
  • 444.   Ravdin PM, Cronin KA, Howlader N et al The decrease in breast-cancer incidence in 2003 in the United States. N Eng J Med 2007; 356: 1670-74.
  • 445.   Beral V; Million Women Study Collaborators, Bull D, Green J, Reeves G. Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 2007; 369 (9574): 1703-10.
  • 446.   Roberts H. Managing the menopause. BMJ 2007; 334: 736-741.
  • 447.   Long term hormone replacement therapy with estradiol alone is linked to breast cancer. BMJ 2007; 334: 3434. Lyytinen et al. Breast cancer risk in postmenopausal women using estrogen-only therapy. Obstet Gynecol 2006; 108: 1354-60.

סרטן השד

  • 448.   Harris R. Screening for breast cancer: what to do with the evidence. Am Fam Physician 2007; 75 (11): 1623-1624, 1626.
  • 449.   Buzdar AU. Dietary modification and risk of breast cancer. JAMA 2006; 295:691-2.
  • 450.   Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 2006; 98: 459-71
  • 451.   Bernstein L, Patel AV, Ursin G, Sullivan-Halley J et al. Lifetime recreational exercise activity and breast cancer risk among black women and white women. J Natl Cancer Inst 2005; 97: 1671-9.
  • 452.   Coombs NJ, Taylor R, Wilcken N, Boyages J. Hormone replacement therapy and breast cancer: estimate of risk. BMJ 2005; 331; 347-349.
  • 453.   Chen WY, Manson JE, Hankinson SE, Rosner B et al. Unopposed estrogen therapy and the risk of invasive breast cancer. Arch Intern Med. 2006; 166: 1027-1032.
  • 454.   Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002; 360 (9328): 187-95.
  • 455.   Lie JA, Roessink J, Kjaerheim K. Breast cancer and night work among Norwegian nurses. Cancer Causes Control 2006; 17: 39-44.
  • 456.   Barrett-Connor E, Mosca L, Collins P, Geiger MJ et al; Raloxifene Use for The Heart (RUTH) Trial Investigators. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 2006; 355: 125-137.
  • 457.   Gradishar WJ, Cella D. Selective estrogen receptor modulators and prevention of invasive breast cancer. JAMA 2006; 295: 2784-6.
  • 458.   Dixon JM. Screening for breast cancer BMJ 2006; 332: 499-500.
  • 459.   Irwig L, Houssami N, Armstrong B, Glasziou P. Evaluating new screening tests for breast cancer. BMJ 2006; 332: 678-679.
  • 460.   Kuhl CK, Schrading S, Leutner CC, Morakkabati-Spitz N et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005; 23 (33): 8469-76.
  • 461.   Vogel VG, Costantino JP, Wickerham DL et al; National Surgical Adjuvant Breast and Bowel Project (NSABP). Effects of Tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA. 2006; 295: 2727-2741.
  • a461.   Land SR, Wickerham DL, Costantino JP et al. Patient-reported symptoms and quality of life during treatment with Tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial. JAMA. 2006 Jun 21; 295 (23): 2742-51.
  • 462.   Moss SM et al;Trial Management Group. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet 2006; 368: 2053-60.

סרטן השחלות

  • 463.   Aletti GD et al. Current management strategies for ovarian cancer. Mayo Clin Proc 2007; 82: 751-70.
  • 464.   van Nagell JR Jr et al. Ovarian cancer screening with annual transvaginal sonography:findings of 25,000 women screened. Cancer 2007; 109: 1887-96.
  • 465.   Menon U et al. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer. J Clin Oncol 2005; 23: 7919-26.
  • 466.   UK collaborative trial of ovarian cancer screening. Available at: www.uktocs.org.uk accessed June 25, 2007.

סרטן המעי הגס

  • 467.   Baron JA, Cole BF, Sandler RS et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003; 348: 891-9.
  • 468.   Beresford SA, Johnson KC, Ritenbaugh C et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006; 295: 643-654.
  • 469.   Bresalier RS, Sandler RS, Quan H et al; Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005; 352: 1092-102.
  • 470.   Davies RJ, Miller R, Coleman N. Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer 2005; 5: 199-209.
  • 471.   Mulhall BP, Veerappan GR, Jackson JL. Meta-analysis: computed tomographic colonography. Ann Intern Med 2005; 142: 635-50.
  • 472.   Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999; 91: 434-7.
  • 473.   Mandel JS, Church TR, Bond JH et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-7.
  • 474.   Jorgensen OD., Kronborg 0., Fenger C. A randomized study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 2002; 50: 29-32.
  • 475.   Rennert G, Rennert HS, Miron E, Peterburg Y. Population colorectal cancer screening with fecal occult blood test. Cancer Epidemiol Biomarkers Prev 2001; 10: 1165-1168.
  • 476.   Rennert G. Dietary intervention studies and cancer prevention. Eur J Cancer Prev 2002; 11: 419-425.
  • 477.   Rennert G. Fecal occult blood screening - trial evidence, practice and beyond. Recent Results Cancer Res 2003; 163: 248-253; discussion 264-6.
  • 478.   Rennert G. Diet and cancer: Where are we and where are we going? Proc Nutr Soc 2003; 62: 59-62.
  • 479.   Poynter JN, Gruber SP, Higgins PD, Almog R et al. Statins and the risk of colorectal cancer. N Eng J Med. 2005; 352: 2184-92.
  • 480.   Brenner DE, Rennert G. Fecal DNA biomarkers for the detection of colorectal neoplasia: attractive, but is it feasible?. J Natl Cancer Inst 2005; 97: 1107-1109.
  • 481.   Rennert G, Almog R, Tomsho LP, Low M et al. Colorectal polyps in carriers of APC I1307K polymorphism. Dis Colon Rectum 2005; 48: 2317-21.
  • 482.   Rennert G, Kislitsin D, Brenner DE, Rennert HS, Lev Z. Detecting K-ras mutations in stool from fecal occult blood test cards in multiphasic screening for colorectal cancer. Cancer Lett 2007; 253: 258-64.
  • 483.   Rennert G. Prevention and early detection of colorectal cancer - new horizons. Recent Results Cancer Res 2007; 174 (15): 179-187.
  • 484.   Boggs BD, Stephens MM, Wallace R. Clinical inquiries. How does colonoscopy compare with fecal occult blood testing as a screening tool for colon cancer? J Fam Pract 2005; 54 (11): 996-997.

סרטן הריאה

  • 485.   International Early Lung Cancer Action Program Investigators; Henschke CI, Yankelevitz DF, Libby DM et al. Survival of patients with stage I lung cancer detected on CT screening. N Eng J Med 2006; 355 (17): 1763-71.
  • 486.   Ganti AK, Mulshine JL. Lung cancer screening. Oncologist 2006 11 (5): 481-7.
  • 487.   Gleeson FV. Is screening for lung cancer using low dose spiral CT scanning worthwhile? Thorax 2006; 61 (1): 5-7.

סרטן הערמונית

  • 488.   Ilic D, O'Connor D, Green S, Wilt T. Screening for prostate cancer. Cochrane Database Syst Rev 2006; 19(3) CD004720.
  • 489.   Roobol MJ, Grenabo A, Schroder FH, Hugosson J. Interval cancers in prostate cancer screening; comparing 2- to 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam. J Natl Cancer Inst 2007; 99: 1296-1303.

מניעה באמצעות תכשירים תרופתיים

  • 490.   פת י. אספירין, האמנם טיפול אידיאלי. כתב העת הישראלי לרפואת המשפחה 2006 כרך 16 מס׳ . 131-130 עמ׳ 14-8.
  • 491.   Berger JS, Roncaglioni MC, Avanzini F et al. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006; 295: 306-13.
  • 492.   Ridker PM, Cook NR, Lee IM et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Eng J Med 2005; 352:1293-304.
  • 493.   Bjelakovic G, Nikolova D, Gluud LL et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta- analysis. JAMA 2007; 297: 842-857.
  • 494.   Miller ER 3rd, Pastor-Barriuso R, Dalal D et al.: Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142: 37-46.
  • 495.   Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005; 293: 2257-64.

ייעוץ גנטי ובדיקות גנטיות לאבחון מוקדם של סרטן

  • 496.   American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility J Clin Oncol. 2003; 21:2397-2406.
  • 499.   http: //www.cancer.gov/cancertopics/pdq/genetics PDQ Cancer Information Summaries of the National Cancer Institute
  • 500.   Nelson HD, Huffman LH, Fu R, Harris EL; U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2005;143:(5): 362-79.

מניעת מחלות לב - כללי

  • 501.   Maciosek MV, Coffield AB, Edwards NM et al. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med 2006; 31 (1): 52-61.
  • 502.   Graham I et al; European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG). European guidelines on cardiovascular disease prevention in clinical practice: executive summary:Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) Eur Heart J 2007; 28: 2375-2414.
  • 503.   Barclay L, Vega C. Advantages and disadvantages of alcohol intake on cardiovascular health reviewed. Medscape- Medical News, Based on J Am Coll Cardiol 2007; 50: 1009¬1014. www.medscape.com/viewarticle/5623547sssdmh=dml.
  • 504.   Ford I, Murray H, Packard CJ, Shepherd J et al. Long term follow-up of the West of Scotland Coronary Prevention Study. N Eng J Med 2007; 357: 1477-1486.

איתור מוקדם של דיכאון

  • 505.   המלצות קליניות לאבחון וטיפול בדיכאון בקהילה בעריכת טבנקין ח, מוניץ ח, גולדפרכט מ, פלד ע. שירותי בריאות כללית שנת 2006.

פעילות גופנית

  • 506.   Knoops KT, de Groot LC, Kromhout D et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 2004; 292: 1433-9.
  • 507.   Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000; 343: 16-22.
  • 508.   משרד הבריאות, חוזר המנהל הכללי מספר 20/05. פעילות גופנית - מרשם לבריאות.
  • 509.   Thompson PD, Buchner D, Pina IL et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 2003; 107: 3109-3116.
  • 510.   Pate RR, Pratt M, Blair SN et al. Physical activity and public health: A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995; 273: 402-407.
  • 511.   Goldstein LB, Adams R, Alberts MJ, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37: 1583-633.
  • 512.   Saris WH, Blair SN, van Baak MA et al. How much physical activity is enough to prevent unhealthy weight gain? Outcome of the IASO 1st Stock Conference and consensus statement. Obes Rev 2003; 4: 101-14.
  • 513.   Lee CD, Blair SN, Jackson AS. Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. Am J Clin Nutr 1999; 69: 373-80.
  • 514.   Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C, White RD. Physical activity/ exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care 2006; 29: 1433-8.
  • 515.   Pescatello LS, Franklin BA, Fagard R et al. American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc 2004; 36: 533-53.
  • 516.   Whelton PK, He J, Appel LJ et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 2002; 288: 1882-8.
  • 517.   Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med 2002; 136: 493-503.
  • 518.   Lee IM. Physical activity and cancer prevention - data from epidemiologic studies. Med Sci Sports Exerc 2003; 35: 1823-7.
  • 519.   Kushi LH, Byers T, Doyle C et al. American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2006; 56: 254-81.
  • 520.   Strong WB, Malina RM, Blimkie CJ, et al. Evidence based physical activity for school- age youth. J Pediatr 2005; 146: 732-7.
  • 521.   Twisk JW. Physical activity guidelines for children and adolescents: a critical review. Sports Med 2001; 31: 617-27.
  • 522.   Bernhardt DT, Gomez J, Johnson MD et al; Committee on Sports Medicine and Fitness. Strength training by children and adolescents. Pediatrics 2001; 107: 1470-2.
  • 523.   Epstein LH, Paluch RA, Kalakanis LE, Goldfield GS, Cerny FJ, Roemmich JN. How much activity do youth get? A quantitative review of heart-rate measured activity. Pediatrics 2001; 108: E44.
  • 524.   American College of Sports Medicine Roundtable Consensus Statement. Impact of physical activity during pregnancy and postpartum on chronic disease risk. Med Sci Sports Exerc 2006; 38: 989-1006.
  • 525.   ACOG Committee Opinion. Number 267, January 2002: exercise during pregnancy and the postpartum period. Obstet. Gynecol 2002; 99: 171-3.
  • 526.   Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 2001; 58: 498-504.
  • 527.   Yaffe K, Barnes D, Nevitt M, Lui LY, Covinsky K. A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch Intern Med 2001;161:1703-8.
  • 528.   Larson EB, Wang L, Bowen JD, McCormick WC, Teri L, Crane P, Kukull W. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med 2006; 144:73-81.
  • 529.   van Gelder BM, Tijhuis MA et al. Physical activity in relation to cognitive decline in elderly men: the FINE Study. Neurology 2004; 63:2316-21.
  • 530.   Verghese J, Lipton RB et al. Leisure activities and the risk of dementia in the elderly. N Engl J Med 2003; 348:2508-16.
  • 531.   Weuve J, Kang JH, et al. Physical activity, including walking, and cognitive function in older women. JAMA 2004; 292: 1454-61.
  • 532.   Rovio S, Kareholt I et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol 2005;4:705-11.
  • 533.   Deary IJ, Whalley LJ et al. Physical fitness and lifetime cognitive change. Neurology 2006; 67: 1195-200.
  • 534.   Heyn P, Abreu BC et al. The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis. Arch Phys Med Rehabil 2004; 85: 1694-704.
  • 535.   Oliver D, Connelly JB, Victor CR et al. Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analyses. BMJ 2007; 334: 82.
  • 536.   Mazzeo RS, Tanaka H. Exercise prescription for the elderly:current recommendations. Sports Med 2001;31:809-18.
  • 537.   Van Sluijs EM, McMinn AM, Griffin SJ. Effectiveness of interventions to promote physical activity in children and adolescents: systematic review of controlled trials. BMJ Oct 2007;335:703.
  • 538.   Young A, Dinan S. Activity in later life. BMJ; 2005; 330: 189-191.
  • 539.   תכנית לימודים בחינוך גופני לגיל הרך - לגן הילדים ולכיתות א׳-ב/ משרד החינוך המזכירות הפדגוגית האגף לתכנון ולפיתוח תכניות לימודים, ירושלים תשס"ז.
  • 540.    תכנית לימודים בחינוך גופני לכיתות ג׳-י"ב משרד החינוך המזכירות הפדגוגית האגף לתכנון ולפיתוח תכניות לימודים, ירושלים תשס"ו.

נזקי העישון

  • 542.   Fiore MC et al. Treating Tobacco Use and Dependence. Clinical Practice Guidelines. U.S. Department of Health and Human Services. Public Health Service June 2000.(Respir Care. 2000 Oct;45(10):1196-9. Treating tobacco use and dependence: an introduction to the US Public Health Service Clinical Practice Guideline. Fiore MC.)
  • 543.    Schroeder SA. What to do with a patient who smokes. JAMA, July 27, 2005; 294(4): 482-487.
  • 544.   Lancaster T, Stead L. Cochrane Database Syst Rev. 2004 Oct 18; (4).
  • 545.   Stead LF, Perera R, Lancaster T Cochrane Database Syst Rev. Cochrane Database Syst Rev. 2006 Jul 19; 3.
  • 546.   Lancaster L and Stead LF. Cochrane Database of Systematic Reviews 2007 Issue 1.
  • 547.   A clinical practice guideline for treating tobacco use and dependence: a US Public Health Service Report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. JAMA 2000; 283: 3244-54.
  • 548.   National Institute for Health and Clinical Excellence. Technology appraisal no 39. Guidance on use of Nicotine replacement therapy (NRT) and bupropion for smoking cessation. London, England: NICE; 2002.
  • 549.   Fiore MC and Schroeder LL. Effective interventions for persons who use tobacco. Key findings from the United States Public Health Service clinical practice guideline: Treating tobacco use and dependence. Journal of Clinical Psychiatry Monographs. 2003; 18 (1): 64-73.
  • 550.   Silagy C, Lancaster T, Stead LF, Mant D: Nicotine replacement therapy for smoking cessation. The Cochrane Database of systemic reviews 2007. DOI 10.1002/ 14651858. CD000146.Pub2.
  • 551.   Hughes JR, Lancaster T Stead LF: Antidepressants for smoking cessation. The Cochrane Database of systemic reviews 2007. DOI 10.1002/14651858.CD000031 .Pub3.
  • 552.   Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. The Cochrane Database of Syst Rev 2007(1). DOI 10.1002/14651858.CD006103.Pub2.
  • 553.   Oncken C, Gonzales D, Nides M et al. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch Intern Med. 2006; 166: 1571-1577.
  • 554.   Jorenby DE, Hays JT, Rigotti NA et al; Varenicline Phase 3 Study Group. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA. 2006; 296: 56-63.
  • 555.   Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. JAMA. 2006; 296: 47-55.

חיסונים

  • 560.   Wright TC, Bosch FX, Franco EL et al. Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts. Vaccine 2006; 24: Suppl 3 S3/251-61.
  • 561.   Bornstein J, Rahat MA, Abramovici H. Etiology of cervical cancer: current concepts.Obstet Gynecol Surv 1995; 50: 146-154.
  • 562.   Koutsky LA, Ault KA, Wheeler CM et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347: 1645-51.
  • 563.   Mao C, Koutsky LA, Ault KA et al. Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstet Gynecol 2006; 107: 18-27
  • 564.   Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6,11,16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005; 6: 271-78.
  • 565.   Harper DM, Franco EL, Wheeler C et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004; 364: 1757-65.
  • 566.   Harper DM, Franco EL, Wheeler CM et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. The Lancet 2006; 367 (9518): 1247-55
  • 567.   ACIP recommendations to CDC. Last accessed Sep 11,2006. http: //www.cdc.gov/OD/OC/ MEDIA/pressrel/r060629.htm
  • 568.   ACOG Committee Opinion No. 344. Human Papillomavirus Vaccination. Obstet Gynecol 2006; 108; 699-785.
  • 569.   Bresee JS, Parashar UD, Widdowson MA et al. Update on rotavirus vaccines. Pediatr Infect Dis J 2005; 24 (11): 947-952.
  • 570.   Glass RI and Parashar UD. The promise of new rotavirus vaccines. N Eng J Med 2006; 354: 75-77.
  • 571.   Bleshe RB, Edwards KM, Vesikari T et al. Live attenuated versus inactivated influenza vaccine in young children. N Eng J Med 2007; 356: 685-696.
  • 572.   Temte J. Childhood and Adolescent Immunization Schedules: Evolution or Intelligent Design. Am Fam Physician 2007; 75 (1): 117-118.
  • 573.   אניס א. מתן חיסון פעיל נגד אבעבועות רוח. חוזר משרד הבריאות 11/2007 שירותי בריאות הציבור משרד הבריאות בישראל 2007.
  • 574.   סלייטר פ. עדכון תדריך החיסונים של המחלקה לאפידמיולוגיה, משרד הבריאות 2007.

רפואה מונעת מגיל 65 ומעלה

  • 576.   Avenell A et al. Vitamin D and Vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2005 Jul 20; (3) CD000227.
  • 577.   Alvarez-Leon EE, Roman-Vinas B, Serra-Majem L. Dairy products and health: a review of the epidemiological evidence. Br J Nutr 2006; 96: S94-99.
  • 578.   Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschueren D, Haentjens P. Need for additional Calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative meta analysis of randomized controlled trials. J Clin Endocrinol Metab. 2007 Apr; 92 (4): 1415-23. Epub 2007 Jan 30.
  • 579.   Dietary Reference Intakes (DRIs): Recommended Intakes for Individuals, Elements, Food and Nutrition Board, Institute of Medicine, US National Academy of Sciences, 2004.
  • 580.   Krall EA et al. Calcium and vitamin D supplements reduce tooth loss in the elderly. Am J Med. 2001; 111:452-6.
  • 581.   Wicherts IS et al. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab. 2007 Jun; 92 (46): 2058-65. Epub 2007 Mar 6.
  • 582.   Gorham ED et al. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta-analysis. Am J Prev Med 2007; 32: 210-6.
  • 583.   Ahonen MH et al. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes & Control 2000; 11: 847-852.
  • 584.   Hochwald O, Harman-Boehm I, Castel H. Hypovitaminosis D among inpatients in a sunny country. Isr Med Assoc J 2004; 6: 82-7.
  • 585.   Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004; 79: 362-71.
  • 586.   Grant WB, Holick MF. Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev 2005; 10: 94-111.
  • 587.   Holick MF. Vitamin D Deficiency. N Engl J Med 2007; 357: 266-81.
  • 588.   Vieth R. Why the optimal requirement for vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol 2004; 89-90: 575-9.
  • 589.   Hanley DA, Davison KS. Vitamin D insufficiency in North America. J Nutr 2005; 135: 332-7.
  • 590.   Bischoff-Ferrari HA, Willett WC, Wong JB et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005; 293: 2257-64.
  • 591.   Heaney RP. Personal communication, July 25, 2007. Vitamin D in health and disease. Clin J Am Soc Nephrol 2008; 3: 1535-41.
  • 592.   Warburton DE, Nicol CW, Bredin SS. Prescribing exercise as preventive therapy. CMAJ 2006; 174: 961-74.
  • 593.   Smith PP, McCrery RJ, Appell RA. Current trends in the evaluation and management of female urinary incontinence. CMAJ 2006; 175: 1233-40.
  • 594.   Ganz DA, Bao Y, Shekelle PG, Rubenstein LZ. Will My Patient Fall? JAMA. 2007; 297: 77-86.
  • 595.   Chang JT et al. Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials. BMJ 2004; 328: 680.
  • 596.   McClure R et al. Population-based interventions for the prevention of fall-related injuries in older people. Cochrane Database Syst Rev 2005. Art no CD004441. DOI 10.102/14651858 CD004441 pub 2.
  • 597.   Alberti KG et al. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-1062.

המלצות ליישום הנחיות לקידום בריאות ורפואה מונעת

  • 600.   Hettema, J, Steele J, Miller WR. Motivational interviewing. Annu Rev Clin Psychol 2005; 1: 91-111.
  • 601.   Rubak S, Sandbaek A, Lauritzen T, Christensen B. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract 2005; 55: 305-312.
  • 602.   Detailed Overview of the Transtheoretical Model [of the Cancer Prevention Research Center]. http: //www.uri.edu/research/cprc/TTM/detailedoverview.htm
  • 603.   van Sluijs EM, van Poppel MN, van Mechelen W. Stage-based lifestyle interventions in primary care: are they effective? Am J Prev Med 2004; 26: 330-343.
  • 604.   Hurling R. Et al. Using internet and mobile phone technology to deliver an automated physical activity program: randomized controlled trial. J Med Internet Res. 2007; 27; 9 (2): e7.

אורתופדיה מניעתית - כאבי גב תחתון

  • 605.   הנחיות קליניות בנושא: מניעה וטיפול בכאבי גב תחתון, ערוך ע"י ד"ר שמואל רייס, ד"ר אמנון להד וקבוצת העבודה הישראלית לכתיבת ההנחיות הקליניות לכאבי גב תחתון. הר"י האגף למדניות בריאות 2007.
  • 606.   Burton AK, Balague F, Cardon G, Erisen HR, Henrotin Y, Lahad A, Leclerc A, Muller G, van der Beek AJ; COST B13 Working Group on European Guidelines for Prevention in Low Back Pain. How to prevent low back pain. Best Pract Res Clin Rheumatol 2005; 19; 541-555, This chapter is a summary of the European Guidelines for Prevention in Low Back Pain: Federico Balague, Greet Cardon, Hege R Eriksen, Osmo Ha nninen, Emma Harvey, Yves Henrotin, Aage Indahl, Amnon Lahad, Annette Leclerc, Gerd Miiller, Allard van der Beek.
  • 607.   Burton AK, Balague F, Cardon G, Eriksen HR, Henrotin Y, Lahad A, Leclerc A, Miiller G, van der Beek AJ; COST B13 Working Group on Guidelines for Prevention in Low Back Pain. Chapter 2. European guidelines for prevention in low back pain:November 2004. Eur Spine J 2006; 15 (Suppl. 2): S136-S168. DOI 10.1007/ s00586-006-1070-3].
  • 608.   EUROPEAN GUIDELINES FOR PREVENTION IN LOW BACK PAIN November 2004. AK Burton F Balague G Cardon HR Eriksen Y Henrotin A Lahad A Leclerc G Miiller AJ van der Beek, On behalf of the COST B13 Working Group on Guidelines for Prevention in Low Back Pain, www.backpaineurope.org
  • 609.   להד א, שריג-בהט ה. קווים מנחים קליניים למניעה כאבי גב תחתון: הרפואה 2007, 146, עמודים 253-7.

העייפות במרפאת הרפואה הראשונית

  • 610.   Soldatos CR et al. How do individuals sleep around the world? Results from a single-day survey in ten countries. Sleep Med 2005; 6:5-13.
  • 611.   http://www.science.education.nih.gov/supplements/nih3/sleep/guide/info-sleep.htm.
  • 612.   INHIS and KAP surveys, Israel Center for Disease Control and MOH Department of Health Promotion and Education, 2003-4.
  • 613.   Irwin MR et al. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med. 2006; 166: 1756-62.
  • 614.   Kahn-Greene ET et al. The effects of sleep deprivation on symptoms of psychopathology in healthy adults. Sleep Med. 2007; 8: 215-21. Epub 2007 Mar 26.
  • 615.   Alvarez GG, Ayas NT. The impact of daily sleep duration on health: a review of the literature. Prog Cardiovasc Nurs. 2004; 19: 56-9.
  • 616.   Knutson KL et al. The metabolic consequences of sleep deprivation. Sleep Med Rev. 2007; 11: 163-78. Epub 2007 Apr 17.
  • 617.   Rains JC, Poceta JS. Headache and sleep disorders: review and clinical implications for headache management. Headache. 2006 Oct; 46 (9): 1344-63.
  • 618.   Wolkove N et al. Sleep and aging: 1. Sleep disorders commonly found in older people. CMAJ 2007; 176: 1299-304.
  • 619.   Morin AK, Jarvis CI, Lynch AM. Therapeutic options for sleep-maintenance and sleep-onset insomnia. Pharmacotherapy. 2007 Jan; 27 (1): 89-110.
  • 620.   Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-5.
  • 621.   Insomnia: Assessment and management in primary care. National Center on Sleep Disorders Research and Office of Prevention, Education, and Control. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute, NIH Publication No. 98A088, September 1998. And Insomnia: assessment and management in primary care. National Heart, Lung, and Blood Institute Working Group on Insomnia.[No authors listed] Am Fam Physician. 1999 Jun;59(11):3029-38. Review.
  • 622.   van den Berg J, Neely G. Performance on a simple reaction time task while sleep deprived. Percept Mot Skills 2006 Apr; 102: 589-99.
  • 623.   Kendall AP et al. Effects of sleep deprivation on lateral visual attention. Int J Neurosci. 2006; 116: 1125-38.
  • 624.   Killgore WD, Balkin TJ, Wesensten NJ. Impaired decision making following 49 h of sleep deprivation. J Sleep Res. 2006 Mar; 15: 7-13.
  • 625.   Rajaratnam SM, Arendt J. Health in a 24-h society. Lancet. 2001; 358: 999-1005.
  • 626.   Connor J et al., Driver sleepiness and risk of serious injury to car occupants: population based case control study. BMJ 2002; 324: 1125-1129.
  • 627.   Belanger L et al. Insomnia and generalized anxiety disorder: effects of cognitive behavior therapy for gad on insomnia symptoms. J Anxiety Disord 2004; 18: 561-71.
  • 628.   Brasic JR. Screening people with disturbed sleep for depression. Percept Mot Skills 2006 Dec; 103: 765-6.
  • 629.   Ohayon MM, Lemoine P. Sleep and insomnia markers in the general population. [Article in French] Encephale. 2004; 30: 135-140.

רפואת מטיילים ומניעת תחלואה בטיסה

  • 630.   Waterhouse J et al. Jet lag: trends and coping strategies. Lancet 2007; 369: 1117-29.
  • 631.   Ansari MT et al. Traveler's thrombosis: a systematic review. J Travel Med 2005;12:142-5.
  • 632.   Schreijer AJ et al. Activation of coagulation system during air travel: a crossover study. Lancet 2006; 367: 832-8.
  • 633.   Brenner B. Interventions to prevent venous thrombosis after air travel, are they necessary? Yes. J Thromb Haemost 2006; 4:2302-5.
  • 634.   Zitter JN et al. Aircraft cabin air recirculation and symptoms of the common cold. JAMA 2002; 288: 483-6.
  • 635.   Mangili A, Gendreau MA. Transmission of infectious diseases during commercial air travel. Lancet 2005; 365: 989-96.
  • 636.   CDC Health Information for International Travel 2008. - The Yellow Book
  • 637.   Gahlinger PM. Motion sickness. How to help your patients avoid travel travail. Postgrad Medicine 1999; 106:177-84. [accessed at http://www.postgradmed.com/issues/1999/10_01_99/gahlinger.htm on June 1, 2007].

מניעה ואיתור מוקדם של מחלות ממאירות

  • 642.   U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med. 2005 Sep 6; 143 (5): 355-61.
  • 643.   Jankowski J, Boulton E. Cancer prevention. BMJ 2005; 331:618.

מניעה כללי

  • 646.   U.S. Preventive task force Guide to Clinical Preventive Services. UPdates 2006-2007 www.ahrg.gov
  • 647.   U.S. Preventive Services Task Force. Screening for abdominal aortic aneurysm: recommendation statement. Ann Intern Med 2005; 142: 198-202.
  • 648.   ליבוביץ פ, יאנקו י. פעילות גופנית בקרב חולים פסיכיאטריים: השפעות בריאותיות ופסיכולוגיות. הרפואה 2007, כרך 146, חוב׳ י"ב, עמ׳ 979-975.
  • 649.   יאנקו: אולמר א. מבחן המיני-מנטל. הרפואה 2006; כרך 145, חוב׳ 9: עמ׳ 690-687.
  • 650.   Willi C, Bodenmann P, Ghali WA et al. Active smoking and the risk of type 2 diabetes. a systematic review and meta-analysis. JAMA 2007; 298 (22): 2654-2664.
  • 651.   The Future II Study Group. Quadrivalent vaccine against human papilloma virus to prevent high-grade cervical lesions. N Engl J Med 2007; 356 (19) 1915-1927.
  • 652.   Update on pediatric vaccines, medical media publications, 2007. www.medicalmedia. co.il/Publications.